Entwicklung einer Zweiphasen-/Zweikomponenten-Strahlpumpenkaelteanlage zur Nutzung solarer Niedertemperaturwaerme Abschlussbericht

A solar refrigerator for air conditioning and cooling was developed. The key component is a two-phase, two-component jet pump with ammonia and water as working fluid. Both the pump flow and the suction flow can be two-phase flows. This way, the advantages of both the absorption and the compression principle will be utilized, and a compact size will be achieved. Upon termination of the calculations, the function of the pump will be investigated in a 0 W pilot plant. For this, various geometries were calculated and tested for their potential efficiencies. A prototype will be constructed on the basis of the results.Das Ziel des Vorhabens besteht in der Entwicklung einer solarbetriebenen Kaelteanlage fuer Klimatisierungs- und Kuehlungszwecke. Die Hauptkomponente der Kaelteanlage ist eine Zweiphasen-/Zweikomponenten-Strahlpumpe, die mit dem Arbeitsgemisch Ammoniak/Wasser betrieben wird. Sowohl der Treib- als auch der Saugstrom koennen zweiphasig sein. Dadurch sollen einerseits die Vorteile des Absorptions- und des Kompressionsprinzips miteinander verknuepft und andererseits ein kompakter Aufbau erreicht werden. Nach Abschluss der thermodynamischen und kinetischen Berechnungen soll die Funktion der Zweiphasen-/Zweikomponenten-Strahlpumpe mit Hilfe einer Pilotanlage mit ca. 20 kW Kaelteleistung untersucht werden. Dazu werden nach Vorausberechnungen verschiedene Geometrien in Bezug auf erzielbare Wirkungsgrade getestet. Die Ergebnisse bilden die Basis fuer den Bau eines Prototyps. (orig.)SIGLEAvailable from TIB Hannover: F02B655 / FIZ - Fachinformationszzentrum Karlsruhe / TIB - Technische InformationsbibliothekBundesministerium fuer Bildung und Forschung, Berlin (Germany); Forschungszentrum Juelich GmbH (Germany)DEGerman

Verfahren zur Aufbereitung gebrauchter Biooele Abschlussbericht

SIGLEAvailable from TIB Hannover: F01B524 / FIZ - Fachinformationszzentrum Karlsruhe / TIB - Technische InformationsbibliothekFachagentur Nachwachsende Rohstoffe e.V., Guelzow (Germany); Bundesministerium fuer Ernaehrung, Landwirtschaft und Forsten, Bonn (Germany)DEGerman

Grundlagenuntersuchung Absorptionswaermepumpe mit Antrieb durch Waerme von mittlerer Temperatur (''Waermetransformator'')

SIGLEDEGerman

Impact of lympho-vascular space invasion on tumor characteristics and survival outcome of women with low-grade serous ovarian carcinoma

BACKGROUND AND OBJECTIVES: To examine association of lympho-vascular space invasion (LVSI) with clinico-pathological factors and to evaluate survival of women with low-grade serous ovarian carcinoma containing areas of LVSI. METHODS: This is a multicenter retrospective study examining consecutive cases of surgically treated stage I-IV low-grade serous ovarian carcinoma (n = 178). Archived histopathology slides for the ovarian tumors were reviewed, and LVSI was scored as present or absent. LVSI status was correlated to clinico-pathological findings and survival outcome. RESULTS: LVSI was seen in 79 cases (44.4%, 95% confidence interval [CI] 37.1-51.7). LVSI was associated with increased risk of omental metastasis (87.0% vs 64.9%, odds ratio [OR] 3.62, P = 0.001), high pelvic lymph node ratio (median 12.9% vs 0%, P = 0.012), and malignant ascites (49.3% vs 32.6%, OR 2.01, P = 0.035). On multivariable analysis, controlling for age, stage, and cytoreductive status, presence of LVSI in the ovarian tumor remained an independent predictor for decreased progression-free survival (5-year rates 21.0% vs 35.7%, adjusted-hazard ratio 1.57, 95%CI 1.06-2.34, P = 0.026). LVSI was significantly associated with increased risk of recurrence in lymph nodes (OR 2.62, 95%CI 1.08-6.35, P = 0.047). CONCLUSION: LVSI in the ovarian tumor is associated with adverse clinico-pathological characteristics and decreased progression-free survival in women with low-grade serous ovarian carcinoma

Impact of Lympho-vascular Space Invasion on Tumor Characteristics and Survival Outcome of Women with Low-grade Serous Ovarian Carcinoma

Background and Objectives: To examine association of lympho-vascular space invasion (LVSI) with clinico-pathological factors and to evaluate survival of women with low-grade serous ovarian carcinoma containing areas of LVSI. Methods: This is a multicenter retrospective study examining consecutive cases of surgically treated stage I-IV low-grade serous ovarian carcinoma (n = 178). Archived histopathology slides for the ovarian tumors were reviewed, and LVSI was scored as present or absent. LVSI status was correlated to clinico-pathological findings and survival outcome. Results: LVSI was seen in 79 cases (44.4%, 95% confidence interval [CI] 37.1-51.7). LVSI was associated with increased risk of omental metastasis (87.0% vs 64.9%, odds ratio [OR] 3.62, P = 0.001), high pelvic lymph node ratio (median 12.9% vs 0%, P = 0.012), and malignant ascites (49.3% vs 32.6%, OR 2.01, P = 0.035). On multivariable analysis, controlling for age, stage, and cytoreductive status, presence of LVSI in the ovarian tumor remained an independent predictor for decreased progression-free survival (5-year rates 21.0% vs 35.7%, adjusted-hazard ratio 1.57, 95%CI 1.06-2.34, P = 0.026). LVSI was significantly associated with increased risk of recurrence in lymph nodes (OR 2.62, 95%CI 1.08-6.35, P = 0.047). Conclusion: LVSI in the ovarian tumor is associated with adverse clinico-pathological characteristics and decreased progression-free survival in women with low-grade serous ovarian carcinoma

Impact of Lympho-vascular Space Invasion on Tumor Characteristics and Survival Outcome of Women with Low-grade Serous Ovarian Carcinoma

Background and Objectives: To examine association of lympho-vascular space invasion (LVSI) with clinico-pathological factors and to evaluate survival of women with low-grade serous ovarian carcinoma containing areas of LVSI. Methods: This is a multicenter retrospective study examining consecutive cases of surgically treated stage I-IV low-grade serous ovarian carcinoma (n = 178). Archived histopathology slides for the ovarian tumors were reviewed, and LVSI was scored as present or absent. LVSI status was correlated to clinico-pathological findings and survival outcome. Results: LVSI was seen in 79 cases (44.4%, 95% confidence interval [CI] 37.1-51.7). LVSI was associated with increased risk of omental metastasis (87.0% vs 64.9%, odds ratio [OR] 3.62, P = 0.001), high pelvic lymph node ratio (median 12.9% vs 0%, P = 0.012), and malignant ascites (49.3% vs 32.6%, OR 2.01, P = 0.035). On multivariable analysis, controlling for age, stage, and cytoreductive status, presence of LVSI in the ovarian tumor remained an independent predictor for decreased progression-free survival (5-year rates 21.0% vs 35.7%, adjusted-hazard ratio 1.57, 95%CI 1.06-2.34, P = 0.026). LVSI was significantly associated with increased risk of recurrence in lymph nodes (OR 2.62, 95%CI 1.08-6.35, P = 0.047). Conclusion: LVSI in the ovarian tumor is associated with adverse clinico-pathological characteristics and decreased progression-free survival in women with low-grade serous ovarian carcinoma